Related Experiment Video
Updated: Jul 29, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Cystic fibrosis: a system for assessing and predicting progression
R H Cleveland1, A S Neish, D Zurakowski
1Department of Radiology, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
A new radiography-based severity curve for cystic fibrosis (CF) patients shows high reliability. This curve, based on chest radiographs, parallels pulmonary function decline and can assess treatment effects.
Area of Science:
- Radiology
- Pulmonology
- Medical Informatics
Background:
- Cystic fibrosis (CF) management requires reliable methods to track disease progression.
- Radiographic scoring systems are crucial for assessing structural lung changes in CF patients.
- Existing methods may benefit from complementary tools for outcome evaluation.
Purpose of the Study:
- To develop and validate a radiography-based database for scoring changes over time in a large cohort of CF patients.
- To establish an age-based severity curve using chest radiograph scores.
- To provide a tool for comparing patient groups undergoing experimental treatments and for individual patient assessment.
Main Methods:
- A database of 3038 chest radiographs from 230 CF patients was scored using the Brasfield system.
- Individual radiograph scores were plotted against patient age to create a single age-based severity curve.
- The derived curve was compared with pulmonary function study data from a subset of the patient population.
Main Results:
- High inter- and intraobserver reliability was achieved, with an average difference of 1.3 points on the 25-point Brasfield scale.
- The age-based severity curve, presented with 95% confidence limits and percentiles, showed a decline rate similar to pulmonary function studies.
- The curve effectively represents structural anatomic changes in CF lung disease.
Conclusions:
- The age-based radiography severity curve offers an independent structural parameter distinct from functional pulmonary assessments.
- This curve serves as a valuable tool for initial disease assessment, gauging decline rates, and predicting disease progression.
- It can be utilized as a long-term outcome criterion for evaluating novel therapeutic interventions in cystic fibrosis.
More Related Videos
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

